Jagsonpal Pharmaceuticals Ltd - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)

We wish to inform you that consequent to the appointment of Mr. Pratham Rawal as Company Secretary, the board of directors have approved changes in KMPs authorized for purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange (s) under the Listing Regulations.